# Diclofenac Sodium by YYBA CORP: new human otc drug listing

**Launch Signal Score:** 40/100

| Field | Value |
|---|---|
| Product | Diclofenac Sodium |
| Generic name | Diclofenac Sodium |
| NDC | 73581-922 |
| Labeler | YYBA CORP |
| Product type | HUMAN OTC DRUG |
| Approval pathway | ANDA |
| Application number | ANDA204306 |
| Dosage form | GEL |
| Route | TOPICAL |
| Active ingredients | DICLOFENAC SODIUM 10 mg/g |
| Marketing start | 2026-10-13 |
| Package configurations | 1 |

## Why this score
- New generic entry: wholesalers and GPOs re-bid contracts.

Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=73581-922). Last refreshed: 2026-11-04T18:12:05.743Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.